ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,101.24
-0.29%
US Tech 100
21,156.80
-0.70%
다우존스 지수
44,424.25
-0.32%
Bitcoin
100,436.20
-2.17%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Compass Therapeutics Inc (CMPX)

  7. Compass Therapeutics Inc (CMPX) 뉴스

Compass Therapeutics Inc

Compass Therapeutics Inc (CMPX)

NASDAQ
2.65
-0.45
(-14.52%)
마감 27 1월 6:00AM
15분 지연
2.65
0.00
(0.00%)
시간외 거래: 9:55AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

CMPX 뉴스

공식 뉴스 전용

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 8월 2024
CMPX (-14.52%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
12 8월 2024
CMPX (-14.52%)

Form 8-K - Current report
Edgar (US Regulatory)
12 8월 2024
CMPX (-14.52%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
10 8월 2024
CMPX (-14.52%)

Form 8-K - Current report
Edgar (US Regulatory)
17 6월 2024
CMPX (-14.52%)

Form 8-K - Current report
Edgar (US Regulatory)
29 5월 2024
CMPX (-14.52%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 5월 2024
CMPX (-14.52%)

Form 8-K - Current report
Edgar (US Regulatory)
13 5월 2024
CMPX (-14.52%)

CMPX Discussion

게시물 보기
Tiger Money Tiger Money 2 일 전
What does this tell you?  Thanks!
👍️0
glenn1919 glenn1919 3 일 전
CMPX...........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 일 전
the upcoming trials....apparently someone(s) may know the results?  The initial indication is that they were very good 
👍️0
Bucks79 Bucks79 4 일 전
broke out after consolidation.. don't see any news released?
👍️0
glenn1919 glenn1919 4 일 전
CMPX..............https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
PonkenPlonken PonkenPlonken 7 일 전
listen to the webcasts and you will find mindblowing things every now and then. Like 6 out of 22 patients with 40% tumor decline in vegf dll4 monotherapy data.
And some people say theres a way to make the machine listen.
👍️0
Tiger Money Tiger Money 1 주 전
Someone must know something.... 
👍️0
Bucks79 Bucks79 2 주 전
a lot of action on this one in the last few days.
👍️0
glenn1919 glenn1919 2 주 전
CMPX........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 주 전
Gap filled 
👍️0
PonkenPlonken PonkenPlonken 3 주 전
and they didnt even speak about it today!
👍️0
Tiger Money Tiger Money 3 주 전
Some very good news out this morning!
👍️0
glenn1919 glenn1919 3 주 전
CMPX..................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 주 전
Thanks!
👍️0
glenn1919 glenn1919 3 주 전
sideways................higher lows.....possible breakout
👍️0
Tiger Money Tiger Money 3 주 전
What does your work tell you on this?  Thanks 
👍️0
glenn1919 glenn1919 3 주 전
cmpx.........................https://stockcharts.com/h-sc/ui?s=cmpxp=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 월 전
CMPX, under $2
👍️0
PonkenPlonken PonkenPlonken 2 월 전
Sorry for the late reply, your question got lost in the mailbox.
I believe 3-6$ isnt unreasonable if they publish a nice readout.

i believe a handful of patients showed more than 30% tumor shrinkage in vegf monotherapy data... I havent seen similar to date...... Nobody listens to webcasts anymore - they probably need an anaylst note to alert them LOL
VEGf space is full of scammers to... everyone jumped the train
👍 1
Tiger Money Tiger Money 2 월 전
If so, where do you think that puts the stock?  Thanks 
👍️0
PonkenPlonken PonkenPlonken 3 월 전
Wouldnt be surprised to see a partner announced in the 10q
👍️0
PonkenPlonken PonkenPlonken 3 월 전
boom coming never before monotherapy data in VEGF space.... a place flooded by bio grifters
👍️0
Monksdream Monksdream 3 월 전
CMPX under $2
👍️0
PonkenPlonken PonkenPlonken 3 월 전
high volume yesterday
👍️0
PonkenPlonken PonkenPlonken 4 월 전
EXCELLENT monotherapy data
VEGF targeted agents usually need the chemo combination to even get a signifcant response. They get it in monotherapy.
I think its going to run into the H1 2025 data.
👍️0
Monksdream Monksdream 5 월 전
CMPX under $2
👍️0
glenn1919 glenn1919 5 월 전
CMPX........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 월 전
CMPX....................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 월 전
CMPX under $2
👍️0
Monksdream Monksdream 10 월 전
CMPX 10Q due 3/25
👍️0
Monksdream Monksdream 10 월 전
CMPX 10Q due 3/18
👍️0
glenn1919 glenn1919 10 월 전
CMPX....................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 월 전
Cant say offhand
Read the latest 10Q
👍️0
stockweiser stockweiser 11 월 전
Do you know there current cash on hand?
👍️0
Monksdream Monksdream 11 월 전
CMPX 10Q due March 11
👍️0
Monksdream Monksdream 1 년 전
CMPX new 52=week low
👍️0
Monksdream Monksdream 1 년 전
CMPX new 52 week low
👍️0
Monksdream Monksdream 1 년 전
CMPX under $2
👍️0
Copilotdog Copilotdog 1 년 전
Solid company
👍️0
Mktman2024 Mktman2024 2 년 전
Compass to review latest phase 2 progress with CTX 009 and other items at ASCO Jan 19-21.
Company moving slowly into the spotlight.
👍️0
Mktman2024 Mktman2024 2 년 전
Reminder CMPX is Compass Therapeutics ,,,EF Hutton new target 10
targets range from 8-15
👍️0
Mktman2024 Mktman2024 2 년 전
https://www.streetinsider.com/Corporate+News/Compass+Therapeutics%2C+Inc+%28CMPX%29+doses+first+patient+in+Phase+1b+CTX-471+combo+with+KEYTRUDA/20920046.html

now were talking!!
👍️0
Mktman2024 Mktman2024 2 년 전
amazing no one posts on any CMPX boards except twitter ...and even then crickets
👍️0
Mktman2024 Mktman2024 2 년 전
The proper company name associated with CMPX symbol
Compass Therapeutics . If one were to review the 6 or 7 bispecifics currently approved for cancer, the efficacy of CTX 009 , CTX 471 and CTX 8371 in early trials is astounding...with a very unique Moa...still not understood by most analysts. It clearly warrants a collaboration with Merck on 471 and potentially many others. The stitchmab they have developed is a real game changing technology optimizing the best suitable mab combinations , along with Taxol, Keytruda and others ...supercharging the efficacy of current drug therapies. This stock has multiple undervalued assets.
👍️0
Mktman2024 Mktman2024 2 년 전
Do you think they like their company ...a little??

Compass Therapeutics, Inc. Insider Trading Activity (benzinga.com)
👍️0
NO birds Allowed NO birds Allowed 2 년 전
dude WTF!!!! another ALLM
👍️0
NO birds Allowed NO birds Allowed 2 년 전
is eh CEO still buying?
👍️0
Mktman2024 Mktman2024 2 년 전
The relative outperformance continues stock sits at 3.05 .Phase 2/3 in US will begin Q4 ...more oustanding data to follow. 3X is easy with this one.
👍️0
Mktman2024 Mktman2024 2 년 전
CEO continues to buy stock buys another 15000 filed 8/17 owns over 5.3 million shares

https://ih.advfn.com/stock-market/NASDAQ/compass-therapeutics-CMPX/stock-news/88862025/statement-of-changes-in-beneficial-ownership-4
👍️0
Mktman2024 Mktman2024 2 년 전
Now we're talking !! 3.00 then 3.27 news might be coming fairly soon
New data plus CTX 009 US trial enrollment . winner..
👍️0

최근 히스토리

NASDAQ
CMPX
Compass Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유